NECTIN2 is a prognostic biomarker and potential therapeutic target in lung adenocarcinoma.
Ando T, Ka M, Sugiura Y, Tokunaga M, Nakagawa N, Iida T, Matsumoto Y, Watanabe K, Kawakami M, Sato M, Kage H.
Ando T, et al. Among authors: matsumoto y.
Respir Investig. 2024 Apr 27;62(4):582-588. doi: 10.1016/j.resinv.2024.04.002. Online ahead of print.
Respir Investig. 2024.
PMID: 38678829